STELLA TABER: Open Payments
NPI 1639723489 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,351 in 54 payments from 21 companies in 2025. Trend: 2023 $1,329 · 2024 $1,494 · 2025 $1,351
Food & beverage: $1,262Education: $89
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $317 |
| Novartis Pharmaceuticals Corporation | 15 | $286 |
| Actelion Pharmaceuticals US, Inc. | 3 | $121 |
| Amgen Inc. | 6 | $101 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Ethicon US, LLC | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
Products named: CARDIOMEMS, LEQVIO, OPSUMIT, REPATHA, BRILINTA, EVKEEZA, ELIQUIS, JARDIANCE.
Industry payments across IN — which companies pay providers there.
